Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
Sparke Helmore Lawyers
This issue examines a number of cases and two contentious issues: the issue of consent and emergency department violence.
Foley & Lardner
These developments present significant opportunities for foreign health care providers and other investors.
Ropes & Gray LLP
The China Food and Drug Administration ("CFDA") recently proposed a draft circular to address the priority review designation issue for medical devices, namely the Circular Regarding Soliciting Comments Regarding Priority Review Designation Procedure for Medical Devices (CFDA Circular [2016] No.40, the "Circular").
Jones Day
Some pioneering industrial players have already made movements in this regard.
Ropes & Gray LLP
China's State Council announced on May 26, 2016, a detailed pilot plan for the Marketing Authorization Holder System ("MAH") for drugs in 10 provinces in China.
Ropes & Gray LLP
On March 23, 2016, the China Food and Drug Administration ("CFDA") and the National Health and Family Planning Commission jointly promulgated the final revision to the 2004 Medical Device Clinical Studies Rules...
King & Wood Mallesons
We have analyzed drug policies with regard to drug pricing and the centralized procurement of drugs in the previous Key 2015 Healthcare and Pharmaceutical Policies: Pharmaceuticals.
In recent years, sponsorships and donations to Healthcare Entities have been the focus of multiple anti-corruption enforcement actions in China.
In recent years, sponsorships and donations to Healthcare Entities have been the focus of multiple anti-corruption enforcement actions in China.
In 2014 we published a report on End of Life Care in the UK and subsequently have written a number of related blogs on this important subject.
TMT Law Practice
""If I said tennis is totally clean, I would be kidding myself [..] I would say there are certainly some short cuts being taken. Not that many, but it would be crazy to think differently." - Nick Bollettieri
PSA Legal Counsellors
This move not only makes clinical trials for academic research on drugs more cost effective and efficient, but also promotes innovation in terms of treatment of critical maladies like AIDS, cancer, etc.
Khaitan & Co
The Competition Appellate Tribunal (COMPAT) on 10 May 2016 has passed a landmark decision setting aside the Competition Commission of India's (CCI) decision in P K Krishnan v Paul Madavana and Ors.
Nishith Desai Associates
A Roundtable on Cloud Computing – Privacy, Security & Legal Compliance Considerations in the Digital Transformation of Healthcare in India, Part 3 (Apr 26, 2016).
It is a well-known fact that India is at par with US, Europe and Australia when it comes to medical treatment and facilities but is considerably less expensive.
Singh & Associates
Post marketing surveillance is performed after market approval/clinical trials of drugs in India.
LexCounsel Law Offices
The Central Drugs Standard Control Organization ("CDSCO") has released draft guidelines in an effort to streamline the regulatory process for granting marketing permission to similar vaccines and other biosimilars in India.
PSA Legal Counsellors
The NPPA has recently issued an office memorandum to clarify the doubts raised by manufacturers and retailers regarding implementation of prices of drugs revised in accordance with the DPCO from time to time.
S.S. Rana & Co. Advocates
This would include names and addresses of sellers, their license numbers, nutrition and ingredient information, food safety details and price parameters.
PSA Legal Counsellors
The FSSAI has launched a new mobile application ("App") which allows food business operators to check their compliance and allows customers to raise complaints regarding food safety.
Most Popular Recent Articles
Singh & Associates
The Indian Patent Office on April 1, 2016 denied Cipla (Applicant) limited a patent for its HIV drug comprising "ritonavir" and "darunavir" involving the patent application 1399/MUMNP/2010 entitled, "Antiretroviral Combination".
Swaab Attorneys
Parties must disclose notice of drug and alcohol abuse in the Notice of Risk document filed at the start of proceedings.
Singh & Associates
The report highlighted for the need for a central legislation for registration of clinical establishments in the country and uniform standards need to be developed for the entire country.
Singh & Associates
According to the eighth annual survey conducted by the Association of Biotechnology-Led Enterprises and Bio Spectrum, the Indian biotech industry grew threefold in just five years to report revenues of US$ 3 billion in 2009-10, a rise of 17 per cent over the previous year.
LexCounsel Law Offices
One of the most shocking news during the recent times for sports fans and legal fraternity, around the globe, has been Maria Sharapova's admittance towards using the banned endurance-enhancing drug known as ‘Meldonium'.
Global Advertising Lawyers Alliance (GALA)
In April 2016, the death of a terminally ill college student, Wei Zexi, outraged China's online community.
Coutts Solicitors & Conveyancers
There are a number of drug and alcohol offences in New South Wales which can see you come before a Magistrate in Court.
Foley & Lardner
These developments present significant opportunities for foreign health care providers and other investors.
Singhania & Partners LLP, Solicitors and Advocates
The Food Safety and Standards Authority of India (FSSAI), India's food regulator has issued new norms for the import, labelling and packaging of products imported to India...
GRATA Law Firm
On 17 May 2016, on the official website of the Eurasian Economic Union (EAEU) a number of decisions of the Council of the Eurasian Economic Commission (EEC) were published.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Font Size:
Mondaq on Twitter